- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01354067
Single Limb Resistance Training in Patients With Chronic Obstructive Pulmonary Disease (COPD) (COPD)
Effects of High-repetitive Single Limb Training on Exercise Capacity and Quality of Life in Patients With COPD Compared to a Control Group - A Prospective, Single Blind, Randomized Controlled Multicenter Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Chronic obstructive pulmonary disease (COPD) is a major cause of chronic morbidity and mortality in the world. It is one of our most common chronic diseases and up to 700.000 people is estimated to suffer from COPD in Sweden. Exercise intolerance is the key disabling factor in COPD, with decreased exercise capacity, leg fatigue and dyspnea among the most frequently reported symptoms.
Different training modalities have been evaluated to uncover the most effective way of training patients with COPD. Traditionally research has used whole-body, or major muscle mass training regimes when investigating the effect of both endurance and resistance in COPD patients. However recent research have demonstrated positive effects using training regimes involving a simultaneous smaller muscle mass compared to traditional exercise. The concept of using this regime is to put less stress on the ventilator system when exercising to minimize the effect of the chronic airflow limitation and to enhance the ability to be able to exercise for this group of patients compared to traditional training using major muscle mass exercise regimes. Although recent research have shown positive effects of single limb training using one-legged cycling, one major limitation is that only a small amount of important muscles for COPD patients are incorporated. Therefore, the aim of this study is to: (i) examine the effect of a single limb exercise regime on local muscle endurance, maximal strength, quality of life, dyspnea, walking capacity, self-efficacy, anxiety and depression, (ii) to examine if the physiological effects differ between man and women and (iii) to investigate if this exercise regime is feasible and safe to use for patients with COPD.
Patients diagnosed with moderate to very severe COPD according to GOLD criteria will be randomly assigned to constitute either an exercise or control group The exercise group will participate in a high-repetitive single limb exercise regime, consisting of upper and lower limb exercises with elastic resistance, compromised of three sessions per week over a period of 8 weeks. The exercise regime will be performed in group at Umeå University Hospital of Northern Sweden, and at Huddinge University Hospital, Sweden supervised by experienced physiotherapists. Both the exercise and control group will receive four sessions of standardized patient education during the 8 week intervention period. After completion of the study, patients in the control group will be offered participation in the single limb exercise regime.
The most important upper and lower extremity muscles for COPD patients are identified and exercises are designed specific to each of these. The exercise regime consists of 8 exercises, 4 upper extremity and 4 lower extremity exercises. Starting position and performance of the exercises are standardized and the resistance individually adjusted and progressed according to rated dyspnea and muscle fatigue.
Before and after the 8 week intervention period the following information will be collected. Effects on maximal strength, muscular endurance, dyspnea, self-efficacy, anxiety and depression. The relationship between changes in health related variables and changes in exercise capacity, sex related differences in training effects, feasibility of the program, strategies to determine adequate starting resistance and provide accurate resistance for each involved movement and the relationship between muscle fatigue and dyspnea in the different exercise tests will also be analyzed.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Huddinge, Sweden, 141 59
- Huddinge University Hospital
-
Umeå, Sweden, 90187
- Umeå University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults 40 years and above.
- Stable (no exacerbations within 4 weeks before start of baseline testing) moderate to very severe COPD, stage II-IV, according to GOLD criteria i.e. Forced expiratory volume in one second (FEV1)/ forced vital capacity (FVC) < 0.70, FEV1 < 80% predicted.
- Ex-smoker.
- Stable medical treatment (no changes < 4 weeks before start of baseline testing).
- Living less than 60 km from training facility.
Exclusion Criteria:
- Musculoskeletal, rheumatic, cardiac or neurological disorders that might affect the exercise performance in training and tests.
- Previous lung surgery.
- Acute exacerbations of COPD that require a change in pharmacological management within four weeks preceding the start of the intervention
- Long-term oxygen treatment.
- Participated in organized exercise training, > 2 times a week, within 6 months before start of intervention.
- Body mass index (BMI) < 18 kg/m2.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Control group
The control group will receive standardized patient education four times, once every two weeks, during the eight week intervention period.
|
The control group receives standardized patient education four times, once every two weeks, during the eight week intervention period.
Each session will last 60 minutes, consisting of information regarding anatomy, physiology, causes and mechanisms of COPD, drugs, nutrition, aids and energy saving procedures.
The information is the same as for the intervention group, given at separate occasions.
|
Experimental: High-repetitive single limb training
The experimental group will receive a high-repetitive single limb exercise regime, three times a week for two months.
In addition, the exercise group will receive patient education at four occasions during the intervention period.
|
The high-repetitive single limb exercise regime consists of three sessions per week during eight weeks of exercise training, giving a total number of 24 sessions at each location (Umeå and Huddinge University hospitals).
The exercise sessions are supervised and conducted by a physical therapist using a group format, six to eight participants in each group.
Each session will span for 60 minutes, duration of the major components are: 10 min warm-up followed by 40 minutes of single limb training and 10min cool-down.
In addition this experimental group also receives four sessions of patient education once every two week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of life
Time Frame: Before single limb exercise regime and on completion (at 8 weeks)
|
The Swedish Self-Administered Standardized version of the Chronic Respiratory Disease Questionnaire (CRQ-SAS) will be used as primary outcome measure to asses quality of life
|
Before single limb exercise regime and on completion (at 8 weeks)
|
Functional lower extremity muscular endurance
Time Frame: Before single limb exercise regime and on completion (at 8 weeks)
|
To asses muscular endurance in the lower extremity the 6-minute walk test will be used as primary outcome measure.
|
Before single limb exercise regime and on completion (at 8 weeks)
|
Upper extremity muscular endurance
Time Frame: Before single limb exercise regime and on completion (at 8 weeks)
|
The 6-minute ring and pegboard test will be used as primary outcome measure for upper extremity muscular endurance
|
Before single limb exercise regime and on completion (at 8 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Isokinetic maximal muscle strength
Time Frame: Before single limb exercise regime and on completion (at 8 weeks)
|
Maximal muscle strength in both upper and lower extremity will be evaluated with an isokinetic dynamometer
|
Before single limb exercise regime and on completion (at 8 weeks)
|
Upper extremity muscular endurance
Time Frame: Before single limb exercise regime and on completion (at 8 weeks)
|
The Unsupported Upper Limb Exercise test will be used as secondary outcome measure for upper extremtiy muscular endurance
|
Before single limb exercise regime and on completion (at 8 weeks)
|
Isokinetic muscular endurance capacity
Time Frame: Before single limb exercise regime and on completion (at 8 weeks)
|
Endurance capacity in both upper and lower extremity will be evaluated with an isokinetic dynamometer
|
Before single limb exercise regime and on completion (at 8 weeks)
|
Self-efficacy
Time Frame: Before single limb exercise regime and on completion (at 8 weeks)
|
Self-efficacy will be evaluated with the exercise self-efficacy scale, and the self-efficacy for walking questionnaire
|
Before single limb exercise regime and on completion (at 8 weeks)
|
Anxiety and Depression
Time Frame: Before single limb exercise regime and on completion (at 8 weeks)
|
Anxiety and Depression will be evaluated with the hospital anxiety and depression scale (HADs)
|
Before single limb exercise regime and on completion (at 8 weeks)
|
Relationship between muscle fatigue and dyspnea in the different exercise tests
Time Frame: Before single limb exercise regime and on completion (at 8 weeks)
|
Muscle fatigue and dyspnea will be measured using the BORG CR10 scale during all exercise tests before the start of the study and on completion 8 weeks later.
The relationship between ratings of muscle fatigue between tests, dyspnea between tests and the relationship between muscle fatigue rating and dyspnea rating between exercise tests will be investigated.
|
Before single limb exercise regime and on completion (at 8 weeks)
|
Develop a strategy to optimize resistance for each involved movement within an exercise regimen
Time Frame: Before single limb exercise regime and on completion (at 8 weeks)
|
The exercises used within the intervention group is performed with elastic resistance.
How much the elastic band is stretched for the different exercises is determined by a literature search investigation the strenght relationship between the muscles/movements used in the study.
During the study each participant in the intervention group will rate muscle fatigue and dyspnea after each exercise during alla exercise sessions.
These rating will be used to develop a strategy to optimize resistance for each involved movement within an exercise regimen
|
Before single limb exercise regime and on completion (at 8 weeks)
|
Develop a strategy to minimize attempts needed to determine a multiple repetition resistance using elastic bands
Time Frame: Before single limb exercise regime and on completion (at 8 weeks)
|
55% of the isokinetic peak value obtained during baseline tests will be used to anticipate the 25RM load when using elastic resistance in an attempt to minimize the attempts needed to achieve 25RM.
|
Before single limb exercise regime and on completion (at 8 weeks)
|
Determine if this exercise regimen is feasible and safe in stage II-IV COPD patients
Time Frame: Before single limb exercise regime and on completion (at 8 weeks)
|
Feasibility will be evaluated through number of participants attendance, adherence and number of participants developing any side effects or injuries during each training session.
In addition, compliance to the different parts of the exercise regimen will be evaluated with a standardized questionnaire by both study participants and physiotherapists leading interventions.
|
Before single limb exercise regime and on completion (at 8 weeks)
|
Identify if there are any sex related differences in exercise training effects
Time Frame: Before single limb exercise regime and on completion (at 8 weeks)
|
Statistical analyzes will be used to identify if there are any sex related differences in exercise training effects between male and female patients with COPD
|
Before single limb exercise regime and on completion (at 8 weeks)
|
Quality-of-life
Time Frame: Before single limb exercise regime and on completion (at 8 weeks)
|
The clinical COPD questionnaire (CCQ) and the SF-36 scale will be used as secondary outcome measures for Quality-of-life
|
Before single limb exercise regime and on completion (at 8 weeks)
|
Exercise capacity
Time Frame: Before single limb exercise regime and on completion (at 8 weeks)
|
A constant work rate test investigating the effects on endurance time, ventilatory response, perceived dyspnea and leg fatigue during submaximal cycle test.
|
Before single limb exercise regime and on completion (at 8 weeks)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Karin Wadell, Ph.D, Umea University
- Study Chair: Andre Nyberg, Msc, Umea University
- Study Chair: Britta Lindström, Ph.D, Umea University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LHM-2011-ANKW
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Disease, Chronic Obstructive
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
Kırıkkale UniversityRecruitingCOPD (Chronic Obstructive Pulmonary Disease)Turkey
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
Clinical Trials on Control group
-
Tasly Pharmaceutical Group Co., LtdCompleted
-
Henan Cancer HospitalRecruitingChemotherapy | Immune Checkpoint Inhibitor | Locally Advanced Gastric CarcinomaChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
International University of La RiojaRecruiting
-
Romanian Society of Anesthesia and Intensive CareUniversity of Medicine and Pharmacy "Victor Babes" Timisoara; Timişoara County...Completed
-
The University of Hong Konghong Kong Cancer FundCompletedBreast Cancer | Yoga Therapy | Shoulder Joint Motion | Scar Contracture
-
University of MaltaNot yet recruiting
-
University of PernambucoUnknown
-
Yonsei UniversityUnknownAdvanced Gastric Cancer | Neoadjuvant Chemotherapy | Palliative ChemotherapyKorea, Republic of
-
Physicians Committee for Responsible MedicineMetropolitan Police Department of Washington, D.C.SuspendedDiabetes Mellitus, Type 2 | Overweight | Blood PressureUnited States